Vision Fund investment portfolio company Vividion Therapeutics's logo

Vividion Therapeutics is utilizing its novel discovery technologies to unlock undruggable targets for oncology and immune disorders.

Leadership
Jeff Hatfield
Fund
SVF2
Status
Acquired
Sector
Health Tech
Region
Americas